S 14161

Known as: S-14161, S14161 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
01220112017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
S14161 is a pan-Class I PI3K inhibitor that induces blood cancer cell death, but its mechanism is largely unknown. In the present… (More)
Is this relevant?
2017
2017
BACKGROUND Coumarins possess a broad spectrum of biological activities and are important pharmacophores in drug developments… (More)
Is this relevant?
2015
2015
Side population (SP) cells are an enriched source of cancer-initiating cells with stemness characteristics, generated by… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
BACKGROUND We previously reported a PI3K inhibitor S14161 which displays a promising preclinical activity against multiple… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Recent studies demonstrated that targeting the phosphatidylinositide 3-kinase (PI3K)/AKT signaling pathway is a major strategy… (More)
Is this relevant?
2014
2014
The phosphatidylinositol 3-kinase (PI3K) signaling pathway is critical in modulating platelet functions. In the present study, we… (More)
  • figure 3
  • figure 4
  • figure 5
  • figure 8
Is this relevant?
2013
2013
Lup-20(29)-en-3H-ol (Lupeol), a dietary triterpene, has been shown to possess multiple pharmacological activities including anti… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
The small chemical compound 8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene (S14161) was recently identified as an inhibitor of… (More)
Is this relevant?
2011
2011
D-cyclins are universally dysregulated in multiple myeloma and frequently overexpressed in leukemia. To better understand the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?